Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...

Protein shakes are made from protein powder derived from animal or plant sources. The FDA does not regulate protein powders as rigorously as prescription medications because they are considered to ...

Premade protein shakes can help there, but picking the right one can be difficult. If you've been struggling to find a non-clumpy protein powder or need to take your protein on the go, we've found ...

FDA approved Unloxcyt (cosibelimab-ipdl) for advanced or metastatic cSCC ahead of its PDUFA date of Dec. 28. Unloxcyt is the first PD-L1 blocking antibody approved for cSCC, with a recommended ...

Best whey-protein powders Best collagen-protein powder Best plant-based protein powders All the other protein powders I’ve tried Protein powders can be found in thousands of formulations on tens ...

In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared ...

FDA approval for Unloxcyt was granted based on clinically meaningful objective response rates and duration of response data, as assessed by an independent central review committee from Study CK ...

2 decision deadline, and extends Vertex’s dominance in the lung disease cystic fibrosis. Prior to Alyftrek’s approval, Vertex had previously brought four cystic fibrosis medicines to market, building ...

Nemluvio is intended for individuals aged 12 years and above with moderate-to-severe atopic dermatitis. Credit: Kmpzzz/Shutterstock. The US Food and Drug Administration (FDA) has approved Galderma‘s ...

Dec. 17, 2024 -- The FDA last week approved Nemluvio for treating moderate to severe atopic dermatitis, a type of eczema, in people aged 12 or older. Nemluvio is to be used with topical ...

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease. The Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L-rknd ...